Based on the Progressive Care Inc stock forecast from 0 analysts, the average analyst target price for Progressive Care Inc is not available over the next 12 months. Progressive Care Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Progressive Care Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Progressive Care Inc’s stock price was USD 1.93. Progressive Care Inc’s stock price has changed by -3.50% over the past week, -17.87% over the past month and -41.52% over the last year.
No recent analyst target price found for Progressive Care Inc
No recent average analyst rating found for Progressive Care Inc
Company Overview Progressive Care Inc
Progressive Care, Inc. operates as a healthcare services and technology company in south Florida. The company provides prescription pharmaceuticals; diagnostics and vaccinations; compounded medications; telepharmacy services; anti-retroviral medications; medication therapy management; and pharmacy services. It also offers durable medical equipment, assisted living facility, senior living, pharmacist consulting, and supply of various prescription medications to long term care facilities. Further, it offers computerized maintenance of patient prescription histories; third party billing; consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system, as well as data analytics services to support health care organizations. Progressive Care, Inc. is based in Hallandale Beach, Florida. Read Less
Progressive Care, Inc. operates as a healthcare services and technology company in south Florida. The company provides prescription pharmaceuticals; diagnostics and vaccinations; compounded medications; telepharmacy services; anti-retroviral medications; medication therapy manage...Read More
Frequently Asked Questions About Progressive Care Inc (RXMD) Stock
Stock Target Advisor's fundamental analysis for Progressive Care Inc's stock is Bearish.
Unfortunately we do not have enough data on RXMD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on RXMD's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on RXMD's stock to indicate if its overvalued.
The last closing price of RXMD's stock was USD 1.93.
The most recent market capitalization for RXMD is USD 0.02B.
Unfortunately we do not have enough analyst data on RXMD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Progressive Care Inc's stock.
As per our most recent records Progressive Care Inc has 105 Employees.
Progressive Care Inc's registered address is 400 Ansin Boulevard, Hallandale Beach, FL, United States, 33009.
You can get more information about it from Progressive Care Inc's website at https://progressivecareus.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RXMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
